Ourofino S.A. OFSA3

BMFBOVESPA · Brazil · Health Technology

BRL 27.00+1.25 (+4.85%)

Market open· Oct 1, 2026, 6:48 PM UTC· BRL · Data may be delayed

Prices may be delayed and are for informational purposes only - not investment advice.

Ourofino S.A. OFSA3

BMFBOVESPA · Brazil · Health Technology

BRL 27.00+1.25 (+4.85%)

Market open· Oct 1, 2026, 6:48 PM UTC· BRL · Data may be delayed

Prices may be delayed and are for informational purposes only - not investment advice.

-1.96% · 6MFull-screen chart

Open BRL 25.75High BRL 27.00Low BRL 25.75Close BRL 27.00Volume 3.60K

Oct 1, 2026

Charts by TradingView Lightweight Charts

Key statistics

Previous close: BRL 25.75
Day range: BRL 25.75 – BRL 27.00
52-week range: BRL 20.90 – BRL 34.69
Volume: 3.60K
Market cap: BRL 1.39B
P/E (TTM): 6.1
Dividend yield (annualized): 4.20%
Next earnings date: 2026-11-05
Avg. volume (1Y): 9.10K

Performance

1 week

+3.85%

1 month

+3.85%

3 months

-6.25%

6 months

-2.43%

Year to date

+20.89%

1 year

+29.34%

Total return, dividends included.

Company profile

Sector: Health Technology
Industry: Pharmaceuticals: Major
Country: Brazil
Exchange: BMFBOVESPA
Shares outstanding: 53.77M
ISIN: BROFSAACNOR7
Beta: 1.04

Technical view

Above averages

Where the price sits against its 50- and 200-day moving averages.

Valuation & analysis

Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.

News

Yahoo FinanceAug 13, 2026

Ourofino SA (BSP:OFSA3) (Q2 2026) Earnings Call Highlights: Strategic Focus on High-Margin ...

Animal health segment leads with 10% revenue growth, while robust cash position of R$365 million supports international expansion and innovation pipeline.

Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.